Marmon Biostatistics
Marmon Biostatistics is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor
Sponsor Sparrow Pharmaceuticals Inc.
- Start (EU)
- Not reported
- Latest update
- Estimated end
Operational learnings available4 trial-level findings · Read insights
- Two global and four regional protocol amendments were implemented to clarify study procedures, eligibility criteria, assessments, ambulatory blood pressure monitoring, and safety monitoring requirements.
- No global trial interruptions or study re-starts affecting trial conduct were reported.
- Early sponsor termination reduced follow-up duration for some participants and may have limited interpretation of longer-term treatment effects.
- The single-arm, open-label study enrolled 23 participants, and the lack of a control group limited direct comparison with placebo or standard therapy.
These findings describe the trial, not the service provider’s performance or responsibility.
A trial of prednisolone in combination with SPI-62 or placebo in participants with polymyalgia rheumatica (PMR)
Sponsor Sparrow Pharmaceuticals Inc.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Marmon Biostatistics?
The 2026-10-09 snapshot links Marmon Biostatistics to 2 distinct CTIS trials. Recorded services include Statistical analysis. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Marmon Biostatistics?
The most frequently recorded therapeutic areas are Endocrinology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Marmon Biostatistics conducted?
The linked trials record locations in 3 countries, including Germany, Poland, Romania. These are trial locations, not confirmed office locations or countries where Marmon Biostatistics delivered services.
What can this page tell me about Marmon Biostatistics's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Marmon Biostatistics. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Marmon Biostatistics